A, G., OO, K., CL, C., X, W., C, H., JG, M., . . . J, Q. (2026). Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma. Neuro-oncology. https://doi.org/10.1093/neuonc/noag142
Chicago Style (17th ed.) CitationA, Groves, et al. "Selective Histone Deacetylase Inhibition as a Therapeutically Relevant Strategy in H3K27M-glioma." Neuro-oncology 2026. https://doi.org/10.1093/neuonc/noag142.
MLA (9th ed.) CitationA, Groves, et al. "Selective Histone Deacetylase Inhibition as a Therapeutically Relevant Strategy in H3K27M-glioma." Neuro-oncology, 2026, https://doi.org/10.1093/neuonc/noag142.
Warning: These citations may not always be 100% accurate.
